Stockreport

Axovant Announces Partnership with Invitae to Increase Access to Genetic Testing and Accelerate Diagnoses of GM1 and GM2 Gangliosidosis

Axovant Gene Therapies Ltd.  (AXGT) 
Last axovant gene therapies ltd. earnings: 2/10 06:00 am Check Earnings Report
PDF Partnership to reduce barriers to genetic diagnosis through sponsored testing for lysosomal storage diseases Initiative supports identification of patients with GM1 [Read more]